Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study

Affiliations

• ¹ aShanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
• ² bHarbin Medical University Cancer Hospital, Harbin, China.
• ³ cHunan Cancer Hospital, Changsha, China.
• ⁴ dThe First Affiliated Hospital of Nanchang University, Nanchang, China.
• ⁵ eThe Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
• ⁶ fZhejiang Cancer Hospital, Hangzhou, China.
• ⁷ gThe Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
• ⁸ hFirst Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
• ⁹ iFujian Provincial Cancer Hospital, Fuzhou, China.
• ¹⁰ jShandong Cancer Hospital and Institute, Affiliated to Shandong University, Jinan, China.
• ¹¹ kShandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.
• ¹² lJilin Cancer Hospital, Changchun, China.
• ¹³ mThe First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China.
• ¹⁴ nJiangxi Cancer Hospital, Nanchang, China.
• ¹⁵ oWest China Hospital of Sichuan University, Chengdu, China.
• ¹⁶ pQingdao Cancer Prevention and Treatment Research Institute, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
• ¹⁷ qOncology Department, Fuzhou Pulmonary Hospital of Fujian, Fuzhou, China.
• ¹⁸ rLinyi People's Hospital, Linyi, China.
• ¹⁹ sThe Second Department of Medical Oncology, Yunnan Cancer Hospital, Kunming, China.
• ²⁰ tThe Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
• ²¹ uXiangya Hospital Central South University, Changsha, China.
• ²² vThe First Affiliated Hospital of University of South China, Changsha, China.
• ²³ wThe First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
• ²⁴ xTangshan People's Hospital, Tangshan, China.
• ²⁵ yBeijing Cancer Hospital, Beijing, China.
• ²⁶ zThe Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
• ²⁷ aaArmy Medical Center of Excellence (Daping Hospital), Chongqing, China.
• ²⁸ bbThe First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
• ²⁹ ccSichuan Provincial Cancer Hospital, Chengdu, China.
• ³⁰ ddCancer Hospital of Shantou University Medical College, Shantou, China.
• ³¹ eeAnhui Provincial Hospital, Hefei, China.
• ³² ffTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
• ³³ ggThird Xiangya Hospital, Central South University, Changsha, China.
• ³⁴ hhTaizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
• ³⁵ iiNingbo Medical Center Lihuili Hospital, Ningbo, China.
• ³⁶ jjJiamusi Tuberculosis Hospital (Jiamusi Cancer Hospital), Jiamusi, China.
• ³⁷ kkThe First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
• ³⁸ llAffiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
• ³⁹ mmThe First Affiliated Hospital of Ningbo University, Ningbo, China.
• ⁴⁰ nnThe First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
• ⁴¹ ooGansu Wuwei Tumor Hospital, Wuwei, China.
• ⁴² ppChongqing University Affiliated Cancer Hospital, Chongqing, China.
• ⁴³ qqAnhui Provincial Cancer Hospital, Hefei, China.
• ⁴⁴ rrPeople's Hospital, Jining, China.
• ⁴⁵ ssThe First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
• ⁴⁶ ttChangsha Central Hospital, Changsha, China.
• ⁴⁷ uuThe First Affiliated Hospital of Anhui Medical University, Hefei, China.
• ⁴⁸ vvThe Second Affiliated Hospital of Xiamen Medical College, Xiamen, China.
• ⁴⁹ wwAffiliated Hospital of Guangdong Medical University, Zhanjiang, China.
• ⁵⁰ xxSummit Therapeutics, Palo Alto, CA, USA.